StonvexLoading…
StonvexStonvexStonvexCore line items from GS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $17.23B | $58.28B | $44.83B | $29.64B |
Operating Income | $6.49B | $21.85B | $16.00B | $10.61B |
Net Income | $5.63B | $17.18B | $12.56B | $8.46B |
EPS (Diluted) | $17.55 | $51.32 | $37.33 | $25.07 |
Total Assets | $2.06T | $1.81T | $1.81T | $1.79T |
Total Liabilities | $1.94T | $1.68T | $1.68T | $1.66T |
Cash & Equivalents | $179.53B | $164.26B | $169.58B | $152.97B |
Free Cash Flow OCF − CapEx | $-32.43B | $-47.22B | $-30.41B | $-32.53B |
Shares Outstanding | 294.57M | 296.48M | 300.12M | 302.85M |